SCLX Q1 2023 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$73M

Q1 2023 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$11M+55.3% YoY

Gross Profit

$7M66.1% margin

Operating Income

-$25M-240.7% margin

Net Income

-$31M-290.6% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

-11.2%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$86M

Total Liabilities

$75M

Stockholders' Equity

$11M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$7M	+55.3%
Gross Profit	$7M	$6M	+23.3%
Operating Income	-$25M	-$9M	-189.3%
Net Income	-$31M	-$9M	-236.4%